Showing results (21-30 of 58) with videos related to
Sort By:
Pageof 6
Contraception|January 30, 2008
A Phase I study of the functional performance, safety and acceptability of the BufferGel DuetSusan A Ballagh, Vivian Brache, Christine Mauck, et al.Contraception: X|August 15, 2022
Return to ovulation after Sayana Press is injected every 4 months for one year: Empirical and pharmacokinetic/pharmacodynamic modeling resultsDouglas J Taylor, Jennifer Deese, Luis Bahamondes, et al.Contraception|April 28, 2022
Acceptability of the contraceptive Sayana® Press when injected every four months: Results from a twelve-month trial in Brazil, Chile and the Dominican RepublicHolly M Burke, Catherine Packer, Rachael Fuchs, et al.Contraception|September 21, 2022
The effect of deliberate non-adherence to a norgestrel progestin-only pill: A randomized, crossover studyAnna Glasier, Alison Edelman, Mitchell D Creinin, et al.Contraception|March 30, 2022
Mechanism of action of norgestrel 0.075 mg a progestogen-only pill. I. Effect on ovarian activityAnna Glasier, Alison Edelman, Mitchell D Creinin, et al.Contraception|October 16, 2012
A multicenter randomized clinical trial of one-rod etonogestrel and two-rod levonorgestrel contraceptive implants with nonrandomized copper-IUD controls: methodology and insertion dataOlav Meirik, Vivian Brache, Kiriwat Orawan, et al.Plos One|November 1, 2011
A multi-compartment, single and multiple dose pharmacokinetic study of the vaginal candidate microbicide 1% tenofovir gelJill L Schwartz, Wes Rountree, Angela D M Kashuba, et al.Contraception: X|November 8, 2021
Suppression of ovulation and pharmacokinetics following subcutaneous administration of various doses of Depo-Provera®: a randomized trialVera Halpern, Rachael Fuchs, Vivian Brache, et al.Contraception|June 14, 2017
A phase I randomized postcoital testing and safety study of the Caya diaphragm used with 3% Nonoxynol-9 gel, ContraGel or no gelChristine K Mauck, Vivian Brache, Thomas Kimble, et al.Contraception|January 13, 2009
Effect of sexual intercourse on the absorption of levonorgestrel after vaginal administration of 0.75 mg in Carraguard gel: a randomized, cross-over, pharmacokinetic studyVivian Brache, Horacio Croxatto, Narender Kumar, et al.Pageof 6